Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Core Insights - Absci Corporation has partnered with U.S. soccer legend Landon Donovan to address the emotional impact of androgenetic alopecia (AGA) and promote the need for innovative therapeutic options [1][3] - Donovan will share his personal experiences with hair loss during Absci's upcoming Key Opinion Leader seminar, emphasizing the importance of patient-driven insights in the development of the investigational antibody ABS-201 [2][3] Company Overview - Absci Corporation is a clinical-stage biopharmaceutical company focused on advancing therapeutics using generative AI, with a commitment to improving patient lives through innovative drug development [1][6] - The company is headquartered in Vancouver, WA, and has an AI Research Lab in New York City, along with an Innovation Center in Switzerland [6] Product Development - ABS-201 is a novel therapeutic targeting prolactin receptors to stimulate hair follicle regeneration, showing statistically significant superior hair regrowth compared to minoxidil in preclinical studies [5] - The company anticipates interim data from its Phase 1/2a HEADLINE study in the second half of 2026, which will provide further insights into the clinical development path and market opportunity for ABS-201 [5] Market Context - Androgenetic alopecia affects approximately 80 million Americans, with current FDA-approved treatments like minoxidil and finasteride offering limited efficacy and notable side effects [4] - The partnership with Donovan aims to destigmatize AGA and highlight the need for better treatment options, reinforcing Absci's commitment to addressing significant unmet medical needs in this area [1][3]